series-a
Stage
2020
Founded
2
Investors
About
NanoSyrinx is a synthetic biology company developing a novel 'Nanosyringe' system to deliver therapeutic proteins and peptides directly to the cytosol of target cells, addressing the challenge of intracellular drug delivery.
Explore NanoSyrinx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.